Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
About 67% of Angion Biomedica's investor base is looking to short. The analysis of current outlook of investing in Angion Biomedica Corp suggests that many traders are alarmed regarding Angion Biomedica's prospects. Angion Biomedica's investing sentiment overview a quick insight into current market opportunities from investing in Angion Biomedica Corp. Many technical investors use Angion Biomedica Corp stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Angion |
NEWTON, Mass., June 01, 2023 Angion Biomedia Corp. , a biopharmaceutical company that has focused on the discovery, development, and commercialization of novel small molecule therapeutics to address fibrotic diseases, today announced that it will effect a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-10. Angions common stock will begin trading on a split-adjusted basis when the market opens on June 2, 2023 under the new tradi
Read at finance.yahoo.com
 |
Angion Biomedica Fundamental Analysis
We analyze Angion Biomedica's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Angion Biomedica using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Angion Biomedica based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Asset
Current Asset Comparative Analysis
Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Angion Biomedica Corp Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Angion Biomedica stock to make a market-neutral strategy. Peer analysis of Angion Biomedica could also be used in its relative valuation, which is a method of valuing Angion Biomedica by comparing valuation metrics with similar companies.
Peers
Angion Biomedica Related Equities
| UNCY | Unicycive Therapeutics | 9.09 | ||||
| PYXS | Pyxis Oncology | 9.01 | ||||
| APLM | Apollomics | 5.62 | ||||
| ZVSA | ZyVersa Therapeutics | 1.96 | ||||
| PALI | Palisade Bio | 1.47 | ||||
| IMMX | Immix Biopharma | 1.44 | ||||
| ELEV | Elevation Oncology | 6.67 | ||||
| ZURA | Zura Bio | 7.50 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in Angion Stock
If you are still planning to invest in Angion Biomedica Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Angion Biomedica's history and understand the potential risks before investing.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |